28561-79-7 Usage
Uses
Used in Pharmaceutical Industry:
1-(4-chloro-phenyl)-1,2-dihydro-indazol-3-one is used as a pharmaceutical compound for its potential to interact with biological systems and modulate specific biological processes. Its unique chemical structure allows it to be a promising candidate for the development of new drugs, particularly in the field of medicinal chemistry.
Used in Medicinal Chemistry:
1-(4-chloro-phenyl)-1,2-dihydro-indazol-3-one is used as a compound in medicinal chemistry for its potential to contribute to the development of new drugs. Its ability to interact with biological systems and modulate specific biological processes makes it a valuable asset in the search for novel therapeutic agents.
Further research and studies are necessary to fully understand the pharmacological potential and potential therapeutic applications of 1-(4-chloro-phenyl)-1,2-dihydro-indazol-3-one. As it stands, its use in the pharmaceutical and medicinal chemistry industries is based on its promising chemical properties and potential for drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 28561-79-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,5,6 and 1 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 28561-79:
(7*2)+(6*8)+(5*5)+(4*6)+(3*1)+(2*7)+(1*9)=137
137 % 10 = 7
So 28561-79-7 is a valid CAS Registry Number.
28561-79-7Relevant academic research and scientific papers
Therapeutic pyrazolo[3,4-B]pyridines and indazoles
-
Page/Page column 14-15, (2008/06/13)
The present invention provides for compounds of Formula I: wherein R2, R3, R4, R5, R6, R7, X, and L have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of central nervous disorders and conditions including attention deficit hyperactivity disorder, neuropathic pain, urinary incontinence, anxiety, depression, and schizophrenia and fibromyalgia. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I.
ACTION OF NITROUS ACID ON N-SUBSTITUTED-ISATINIC ACIDS. DISPROPORTIONATION TO INDAZOLOLS.
Baiocchi,Leandro,Picconi, Giuseppe
, p. 3651 - 3652 (2007/10/02)
By reacting N-substituted-2-isatinic acids with nitrous acid, indazolols, N-nitroso-N-substituted anthranilic acids and the esters of said acids with the above mentioned indazolols were obtained through disproportionation of the N-nitroso-N-substituted-isatinic acids.
